UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055186
Receipt number R000063054
Scientific Title Investigating elderly people's adherence to individualized behavioral change proposals to improve cognitive reserve: A pilot study
Date of disclosure of the study information 2024/08/07
Last modified on 2025/02/06 17:04:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigating elderly people's adherence to individualized behavioral change proposals to improve cognitive reserve: A pilot study

Acronym

Investigating elderly people's adherence to individualized behavioral change proposals to improve cognitive reserve: A pilot study

Scientific Title

Investigating elderly people's adherence to individualized behavioral change proposals to improve cognitive reserve: A pilot study

Scientific Title:Acronym

Investigating elderly people's adherence to individualized behavioral change proposals to improve cognitive reserve: A pilot study

Region

Japan


Condition

Condition

Healthy elderly

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine how the use of a simulation app to predict cognitive function in addition to prevention education on dementia affects Health Belief in healthy older people.

Basic objectives2

Others

Basic objectives -Others

To examine how the use of a simulation app to predict cognitive function in addition to prevention education on dementia affects Health Belief in healthy older people.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Motivation to Change Lifestyle and Health Behaviors for Dementia Risk Reduction, Japanese version

Key secondary outcomes

MMSE, CQ test, Adherence research


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

App use and disease education

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. People over 65 years old
2. Those who have never been diagnosed with dementia
3. Those who have given written consent to participate in this study
4. Those who can use a smartphone or tablet that can access the web

Key exclusion criteria

1. Those who have difficulty responding to rating scales or operating a tablet
2. Those with MMSE score of 23 or less
3. Those who are deemed unsuitable for conducting this research by the research director or researcher

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Mimura

Organization

Keio University

Division name

Center for Preventive Medicine

Zip code

106-0041

Address

Azabudai Hills Mori JP Tower 7th Floor, 1-3-1 Azabudai, Minato-ku, Tokyo

TEL

03-5363-3685

Email

mimura.a7@keio.jp


Public contact

Name of contact person

1st name Taishiro
Middle name
Last name Kishimoto

Organization

Keio University School of Medicine

Division name

Hills Joint Research Laboratory for Future Preventive Medicine and Wellness

Zip code

106-0041

Address

Hills Mori JP Tower 7th Floor, 1-3-1 Azabudai, Minato-ku, Tokyo

TEL

03-5363-3219

Homepage URL


Email

tkishimoto@keio.jp


Sponsor or person

Institute

keio University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical committee Keio University School of Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

Tel

03-3353-1211(62014)

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 08 Month 03 Day

Date of IRB

2024 Year 08 Month 07 Day

Anticipated trial start date

2024 Year 09 Month 01 Day

Last follow-up date

2025 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 08 Month 07 Day

Last modified on

2025 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063054